2470015-35-9

2470015-35-9 structure
2470015-35-9 structure
  • Name: Anticancer agent 43
  • Chemical Name: Anticancer agent 43
  • CAS Number: 2470015-35-9
  • Molecular Formula: C14H9FN2O3S2
  • Molecular Weight: 336.36
  • Catalog: Signaling Pathways Apoptosis Apoptosis
  • Create Date: 2022-05-21 17:04:01
  • Modify Date: 2024-01-09 15:52:49
  • Anticancer Agent 43 is a potent anticancer agent. Anticancer Agent 43 induces apoptosis by caspase 3, PARP1, and Bax dependent mechanisms. Anticancer Agent 43 induces DNA damage[1].

Name Anticancer agent 43
Description Anticancer Agent 43 is a potent anticancer agent. Anticancer Agent 43 induces apoptosis by caspase 3, PARP1, and Bax dependent mechanisms. Anticancer Agent 43 induces DNA damage[1].
Related Catalog
Target

Caspase 3

PARP1

Bax

In Vitro Anticancer agent 43 (compound 3a) shows selectivity toward human tumor cells (SI50=28.94)[1]. Anticancer agent 43 (45 µM, 24 h) induces apoptosis via caspase 3, PARP1 and Bax dependent pathways in HepG2 cells[1]. Anticancer agent 43 (45 µM, 24 h) shows no effect on the transition of G1/S phases in HepG2 cells[1]. Anticancer agent 43 (0.7, 45, 55 µM) induces DNA damage in HCT116 cells (Tail DNA=16.1%, OTM=3.7), MCF-7 cells, HepG2 cells (Tail DNA=26.2%, OTM=13.2), Balb/c 3T3 cells (Tail DNA = 8.4%, OTM = 3.5)[1]. Cell Cytotoxicity Assay[1] Cell Line: HepG2, MCF-7, HCT116, HeLa, A549, WM793, THP-1, HaCaT, Balb/c3T3 cells Concentration: 0, 1, 10, 100 µM Incubation Time: 72 h Result: Showed cytotoxic action with GI50s of 12.1, 0.7, 0.8, 49.3, 9.7 µM for for HepG2, MCF-7, HCT116, HeLa, A549 cells, low toxicity towards WM793, THP-1, HaCaT, Balb/c 3T3 cells with GI50s of 80.4, 62.4,98.3,40.8 µM , respectively. Apoptosis Analysis[1] Cell Line: HepG2 cells Concentration: 45 µM Incubation Time: 24 h Result: Induced apoptosis in HepG2 cells via caspase 3, PARP1 and Bax dependent pathways. Western Blot Analysis[1] Cell Line: HCT116, MCF-7 cells Concentration: 0.7 µM Incubation Time: 24 h Result: Decreased the expression of Cdk2 protein in HCT116 and MCF-7 cells. Cell Cycle Analysis[1] Cell Line: HepG2 cells Concentration: 45 µM Incubation Time: 24 h Result: Showed no effect on the transition of G1/S phases in HepG2 cells.
References

[1]. Kryshchyshyn-Dylevych A, et al. Synthesis of novel indole-thiazolidinone hybrid structures as promising scaffold with anticancer potential. Bioorg Med Chem. 2021; 50:116453.

Molecular Formula C14H9FN2O3S2
Molecular Weight 336.36
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.